In conclusion, COVID-19-related hypercytokinemia shows some correlations with regulation of the Ach/α7nAChR pathway characterized by a decreased expression of the pro-inflammatory dominant negative duplicate CHRFAM7A. Here, CHRFAM7A is linked to COVID-19.